Company: CORT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001628280-25-019942
Chunk: 40

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 40
---
 public accounting firm, for fiscal 2024 and 2023.

|               |     | 2024           
 (in thousands) |       |     | 2023 |       |
|:--------------|:----|:---------------|------:|:----|:-----|------:|
| Audit Fees(1) |     | $              | 2,360 |     | $    | 1,980 |
| Tax Fees(2)   |     |                |   139 |     |      |   150 |
| Total         |     | $              | 2,499 |     | $    | 2,130 |

| (1) |     | Audit fees are for the audit of our financial statements and review of our quarterly financial statements as well as for audit services provided in connection with other statutory or regulatory filings, including consents. |
| (2) |     | Tax fees are for tax advisory and tax compliance services.                                                                                                                                                                     |

Pre-approval of audit-related and non-audit services

In order to ensure that the provision of audit and non-audit services does not impair our independent registered public accounting firm’s independence, our policy is that the Audit Committee must pre-approve such services. Pre-approval may be given annually, as part of the Audit Committee’s review and approval of the scope and estimated cost of audit and non-audit services provided by the independent registered public accounting firm or on case-by-case basis as the need for such services arise. The Audit Committee has delegated to the Chair of the Audit Committee the authority to pre-approve the cost of audit and non-audit services performed by our independent registered public accounting firm, provided that the Chair shall report the decision to pre-approve such services and fees to the full Audit Committee at its next regular meeting. Our Audit Committee receives periodic reports on the scope of services provided and expected to be provided in the future by our independent registered public accounting firm.

In 2024 and 2023, all audit and non-audit services (including audit-related fees, tax fees and all other fees) performed by our independent registered public accounting firm, Ernst & Young LLP, were pre-approved by the Audit Committee.

<div align='center'>33

PROPOSALS TO BE ACTED UPON AT THE 2025 ANNUAL MEETING</div>

#### PROPOSAL NO. 1

### ELECTION OF DIRECTORS
At the 2025 Annual Meeting, the stockholders will vote on the election of nine directors